Meeting Abstract
Authors list: Bonn, B; Strängberg, E; Uzelac, I; Kirstgen, M; Goldmann, N; Glebe, D; Geyer, J; Lindström, E
Publication year: 2022
Pages: A42-A42
Journal: Gut
Volume number: 71
Issue number: Suppl. 3
ISSN: 0017-5749
eISSN: 1468-3288
DOI Link: https://doi.org/10.1136/gutjnl-2022-BASL.66
Conference: British Association for the Study of the Liver Annual Meeting
Publisher: BMJ Publishing Group
Citation Styles
Harvard Citation style: Bonn, B., Strängberg, E., Uzelac, I., Kirstgen, M., Goldmann, N., Glebe, D., et al. (2022) The orally available sodium/taurocholate co-transporting polypeptide inhibitor A2342 blocks hepatitis B and D entry in vitro, Gut, 71(Suppl. 3), p. A42. https://doi.org/10.1136/gutjnl-2022-BASL.66
APA Citation style: Bonn, B., Strängberg, E., Uzelac, I., Kirstgen, M., Goldmann, N., Glebe, D., Geyer, J., & Lindström, E. (2022). The orally available sodium/taurocholate co-transporting polypeptide inhibitor A2342 blocks hepatitis B and D entry in vitro. Gut. 71(Suppl. 3), A42. https://doi.org/10.1136/gutjnl-2022-BASL.66
